Sign inJoin waitlistJoin the waitlist

KH

Kristen Hege

Medical Oncology

Credentials: · ·

History

University of California-San Francisco
1992–1995
Internal Medicine
1989–1992
Univ of California, San Francisco Sch of Med
1985–1989

Research

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
New England Journal of Medicine · 2021 · 2,130 citations
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
New England Journal of Medicine · 2019 · 1,419 citations
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells
Science Translational Medicine · 2012 · 528 citations

JN
John Nemunaitis
8 papers
Nikhil Munshi
6 papers
Carl June
5 papers
NS
Natalie Sacks
5 papers
Fabio Petrocca
4 papers
JB
Johanna Bendell
4 papers
MP
Michael Pourdehnad
4 papers
NR
Noopur Raje
4 papers
Ronald Mitsuyasu
4 papers
Steven Deeks
4 papers
DS
David Scadden
3 papers
David Siegel
3 papers

Clinical trials

Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma
Study director · Completed · Phase 2
Celgene
2017–2023
Longterm Follow-up of Subjects Treated With bb2121
Study director · Completed
Celgene
2016–2019
Study of bb2121 in Multiple Myeloma
Study director · Completed · Phase 1
Celgene
2015–2022
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
Study director · Terminated · Phase 1
Celgene
2015–2016